GRM5 and prion disease: Although both Grm5 genetic deletion and mGluR5 pharmacological inhibition (MPEP) did not prevent prion disease, MPEP significantly improved locomotor abilities until the later stage of disease, decreased the size of spongiform vacuoles, and reduced the extent of hippocampal astrogliosis.